Logo 5710 1.25/250 (Glyburide and Metformin 1.25 mg / 250 mg)

Pill imprint Logo 5710 1.25/250 has been identified as Glyburide and metformin hydrochloride 1.25 mg / 250 mg.

Glyburide/metformin is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. There is no proven risk in humans during pregnancy. Glyburide/metformin 1.25 mg / 250 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for Logo 5710 1.25/250

Glyburide and metformin hydrochloride 1.25 mg / 250 mg Logo 5710 1.25/250 Front
Glyburide and metformin hydrochloride 1.25 mg / 250 mg Logo 5710 1.25/250 Back
Glyburide and metformin hydrochloride 1.25 mg / 250 mg Logo 5710 1.25/250
Glyburide and metformin hydrochloride 1.25 mg / 250 mg Logo 5710 1.25/250
Glyburide and metformin hydrochloride
Imprint:
Logo 5710
1.25/250
Strength:
1.25 mg / 250 mg
Color:
Orange
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Antidiabetic combinations
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Teva Pharmaceuticals USA

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web5)